If you’ve spent any time around weight loss surgery, you’ve heard the usual warnings: heart disease, diabetes, joint pain, sleep apnea. What gets mentioned far less is the connection between obesity and cancer, even though it’s one of the most well-documented relationships in modern medicine. The CDC has linked excess weight to at least 13 different types of cancer, together accounting for roughly 40% of all cancers diagnosed in the United States. The encouraging part is that research increasingly shows significant, sustained weight loss, including through bariatric surgery, can measurably lower that risk. Below, we break down what the science actually says, which cancers are most affected, and how procedures like gastric bypass and gastric sleeve surgery fit into a real risk-reduction plan.
Is there a link between obesity and cancer?
Yes, and it’s not a fringe theory. Fat tissue isn’t just stored energy, it behaves like an active organ. In people with obesity, that tissue drives chronic low-grade inflammation, pushes estrogen production higher, and disrupts insulin and insulin-like growth factor (IGF-1) signaling. All three of those pathways are known drivers of tumor growth. This is the obesity and cancer relationship in plain terms: it’s not one single cause, it’s several overlapping biological mechanisms that, together, create an environment where cancer cells have an easier time developing and spreading.
What does the CDC say about obesity and cancer risk?
The CDC’s analysis, one of the most cited studies on the subject, found that overweight and obesity are linked to at least 13 cancer types, which together make up close to 40% of all cancer diagnoses nationwide. Only smoking causes more cancer cases. The 13 cancers currently on that list are:
- Postmenopausal breast cancer
- Colon and rectal (colorectal) cancer
- Esophageal adenocarcinoma
- Uterine (endometrial) cancer
- Ovarian cancer
- Kidney cancer
- Liver cancer
- Gallbladder cancer
- Pancreatic cancer
- Stomach (upper/cardia) cancer
- Thyroid cancer
- Multiple myeloma
- Meningioma (a type of brain tumor)
A large 2022 study out of Spain, following more than two million people, found evidence linking obesity to as many as 18 cancers, some not yet on the official list, which suggests this research area is still actively expanding.
Obesity and breast cancer risk
Of everything in this list, obesity and breast cancer has the strongest supporting evidence, which lines up with its search volume. After menopause, most estrogen in the body is produced by fat tissue rather than the ovaries. More fat tissue means more circulating estrogen, and estrogen fuels the most common type of breast cancer. It’s also the cancer type researchers see respond most consistently to weight-loss surgery: a major Cleveland Clinic study (SPLENDID) found breast and endometrial cancer were the two most common cancers diagnosed in patients who had bariatric surgery, but at meaningfully lower rates than in patients who didn’t have surgery.
Obesity, colon cancer, and colorectal cancer risk
People with obesity have roughly a 30% higher risk of developing colorectal cancer compared to people at a healthy weight. Colon and rectal cancer are both part of the CDC’s core 13, and unlike some of the other cancers on this page, colorectal cancer is one where researchers have found a statistically significant risk reduction after bariatric surgery, not just a trend.
Obesity and prostate cancer: what the research really shows
This is where a lot of content online oversimplifies. The link between obesity and prostate cancer is real, but it’s more nuanced than the breast or colorectal connection. The strongest evidence connects obesity to more aggressive, harder-to-treat prostate cancer and worse outcomes after diagnosis, rather than a straightforward increase in overall incidence. Large studies following patients after bariatric surgery haven’t found a statistically significant drop in prostate cancer rates specifically, even though the surgery clearly helps with other obesity-related cancers. We’d rather tell you that plainly than oversell it.
Ovarian cancer, bladder cancer, and stomach cancer: the lesser-known links
Ovarian cancer sits on the CDC’s list through the same estrogen-driven mechanism as breast and uterine cancer, and it’s one of the cancer types where meta-analyses show a meaningful risk reduction after bariatric surgery. Bladder cancer isn’t part of the official 13, but multiple independent meta-analyses have found obesity is associated with an increased risk of developing it, so it’s a legitimate concern even without CDC’s formal classification. Stomach cancer, specifically cancer of the upper stomach (cardia), is on the CDC list and tied to the same chronic inflammation pathway seen throughout this page.
What about lung cancer and obesity?
This one surprises people. Despite the search volume around “obesity and lung cancer,” major research bodies, including the International Agency for Research on Cancer, don’t classify lung cancer as obesity-linked. In fact, epidemiological data shows an inverse pattern, higher BMI associated with lower lung cancer rates, but researchers attribute this to confounding factors, not a protective effect of excess weight. Smoking (the dominant cause of lung cancer) tends to lower body weight, and undiagnosed lung cancer itself often causes weight loss before diagnosis, which skews the data. We’re including this because accurate information matters more to us than checking a keyword box.
How bariatric surgery reduces cancer risk
This is the part with the most encouraging data. Several large, independent studies, including a Cleveland Clinic analysis known as the SPLENDID study, a University of Utah study following patients over more than a decade, and a Mayo Clinic-cited analysis, have found bariatric surgery is associated with roughly a 25% to 33% reduction in overall cancer risk, with some studies showing up to a 48% reduction in cancer-related deaths. The effect is strongest in women and for hormonally driven cancers like breast, endometrial, and ovarian cancer, and research shows the benefit tends to scale with how much weight is lost.
At BodEvolve, Dr. Frenzel works with patients to determine which procedure fits their health profile and goals. Gastric bypass reroutes part of the digestive system and tends to produce the most significant hormonal shifts, which is part of why it’s associated with some of the strongest cancer-risk reductions in the research. Gastric sleeve removes a portion of the stomach and is currently the most commonly performed procedure nationally, offering substantial and lasting weight loss with a somewhat simpler recovery. If you’re still early in deciding, our guide on how to prepare for bariatric surgery walks through what the process actually looks like before you commit to anything.
GLP-1 medications vs. bariatric surgery for cancer risk reduction
With GLP-1 medications like semaglutide and tirzepatide everywhere right now, it’s a fair question: do they lower cancer risk too? Early research says yes, modestly. A JAMA Oncology study published in August 2025 found GLP-1 receptor agonist use was associated with an overall reduction in cancer risk in adults with obesity, and a 2025 study presented at the American Society of Clinical Oncology found patients on GLP-1 medications had a 7% lower risk of developing an obesity-related cancer compared to a different diabetes medication, with the benefit concentrated mainly in women.
That’s genuinely promising, but it’s also brand-new data. Bariatric surgery has a much longer track record, with studies following patients for a decade or more showing durable, sustained cancer-risk reduction. For patients with significant obesity, especially those who haven’t had lasting success with medication alone, surgery remains the option with the deepest evidence behind it.
Take the next step toward lowering your risk
Understanding the link between obesity and cancer is the first step. Acting on it, with the right medical guidance, is what actually changes your outcome. If you want to see what real patients’ journeys looked like, our weight loss success stories page is worth a look before your first visit.
BodEvolve sees patients across the DFW area and Texarkana, with dedicated care teams in Arlington, Richardson, Dallas, and Texarkana. Schedule a consultation to talk through your health history and find out which path makes sense for you.
